Mark W Green, MD
-
- Positions
- PROFESSOR | Neurology, Headache
- PROFESSOR | Rehabilitation Medicine
- PROFESSOR | Anesthesiology, Perioperative & Pain Medicine
-
- Specialties
- Headache Medicine
- Neurology
-
- Language
- English
-
- Hospital Affiliation
- The Mount Sinai Hospital
-
- Phone
- Center for Headache and Facial Pain 212-241-7076212-241-7076
Mark W. Green, MD, FAAN is the Director of the Center for Headache and Pain Medicine and Professor of Neurology, Anesthesiology, and Rehabiltation at the Icahn School of Medicine at Mount Sinai. He is certified in Neurology by the American Board of Psychiatry and Neurology, and in Headache Medicine through the United Council for Neurologic Subspecialties. He is a fellow in the American Academy of Neurology. Dr. Green has been active in the practice of headache and facial pain since 1978. He has lectured throughout the world on this subject and has written numerous articles on various subjects concerning headache and facial pain.
He was one of the founding editors of Cephalagia, the International Headache Journal. He also served as the Associate Editor of Headache, the journal of the American Headache Society. He has a long-standing interest in neuropharmacology and is a panel member of the Advisory Board of the Food and Drug Administration’s Section on Peripheral and Central Neurological Drugs.
Dr. Green received his medical degree from the Albert Einstein College of Medicine. He received his neurology training at the Albert Einstein College of Medicine and during that period worked in the Montefiore Headache Unit of Albert Einstein. He was later appointed director of that unit. Dr. Green came to Columbia University in 1981, and then New York Medical College. He returned to Columbia University in 2002 to organize a section on headache and facial pain in the department of neurology. There he founded one of the countries first fellowships in headache medicine. He came to Mount Sinai in 2009 from Columbia University, where he was Director of Headache Medicine and Clinical Professor of Neurology (in Neurology, Anesthesiology and Dentistry) at the College of Physicians and Surgeons and the College of Dental Medicine. He then came to Mount Sinai in 2009 to develop and direct a headache center and fellowship in headache medicine.
Certifications
Headache Medicine
Neurology, American Board of Psychiatry and Neurology
Clinical Focus
- Chronic Daily Headache
- Chronic Migraine
- Chronic Paroxysmal Hemicrania
- Cluster Headache
- Low Pressure Headache
- Migraine
- Migraine-Adult
- Occipital Neuralgia
- SUNCT Syndrome
- Sinus Headache
- Tension Headache
Education
MD, Albert Einstein College of Medicine
Internship, Internal Medicine
Albert Einstein Colllege of Medicine/ Montefiore Medical Center
Residency, Neurology
Albert Einstein College of Medicine
Language
English
Download the CV
2016
Lifetime Achievement Award
National Headache Foundation
Green MW, Rothrock JF. An academic debate: OnabotulinumtoxinA for chronic migraine: PREEMPT-derived vs . Toxicon: Official Journal of the International Society on Toxinology 2018 Jun; 147.
Mullen E, Green M, Hersh E, Iloreta AM, Bederson J, Shrivastava R, Armstrong MJ, Gloss D, Potrebic S, Jankovic J, Karp BP, Naumann M, So YT, Yablon SA. Tolosa-Hunt Syndrome: Appraising the ICHD-3 beta diagnostic criteria. Cephalalgia 2018 09; 38(10).
Simpson DM, Hallett M, Ashman EJ, Comella CL, Green MW, Gronseth GS, Armstrong MJ, Gloss D, Potrebic S, Jankovic J, Karp BP, Naumann M, So YT, Yablon SA. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2016 May; 86(19).
Robinson-Papp J, George MC, Wongmek A, Nmashie A, Merlin JS, Ali Y, Epstein L, Green M, Serban S, Sheth P, Simpson DM. The Quantitative Analgesic Questionnaire: A Tool to Capture Patient-Reported Chronic Pain Medication Use. Journal of Pain and Symptom Management 2015 Sep; 50(3).
Dimitrova AK, Ungaro RC, Lebwohl B, Lewis SK, Tennyson CA, Green MW, Babyatsky MW, Green PH. Prevalence of migraine in patients with celiac disease and inflammatory bowel disease. Headache 2013 Feb; 53(2).
Dimitrova AK, Ungaro RC, Lebwohl B, Lewis SK, Tennyson CA, Green MW, Babyatsky MW, Green PH, Serban S, Sheth P, Simpson DM. Prevalence of migraine in patients with celiac disease and inflammatory bowel disease. Headache 2013 Feb; 53(2).
Green M, Muskin P. The Neuropsychiatry of Headache. Cambridge Press 2013;.
Green M, Muskin P. Migraine in Women. In: Epidemiology of Women's Health. Jones & Bartlett, 2013;.
Babineau SE, Green MW, Peterson C, Bhattacharyya A, Tennyson CA, Green MW, Babyatsky MW, Green PH. Headaches in Children. Continuum (Minneapolis, Minn.) 2012 Aug; 18(4).
Bogorad I, Blum S, Green M, Bhattacharyya A, Tennyson CA, Green MW, Babyatsky MW, Green PH. A case of MS presenting with SUNCT status. Headache 2010 Jan; 50(1).
Green MW, Seeger JD, Peterson C, Bhattacharyya A, Tennyson CA, Green MW, Babyatsky MW, Green PH. Utilization of topiramate during pregnancy and risk of birth defects. Headache; 52(7).
Green M, Peterson C, Bhattacharyya A, Tennyson CA, Green MW, Babyatsky MW, Green PH. Headache, Migraine and other Primary Headache Syndromes, Secondary Headache. Lippincott Wilkins 12 Ed, 2009;.
Green M, Peterson C, Bhattacharyya A, Tennyson CA, Green MW, Babyatsky MW, Green PH. Headache. In: Burst J, editor. Current Diagnosis and Treatment in Neurology. McGraw Hill 2010;.
Green M. Burst J, editor. Tension-type headache.
Green M. Riggio S, editor. Headaches and Psychiatric Disorders.
Green M. Riggio S, editor. Headache. American Academy of Neurology July 2012;.
Bogorad I, Blum S, Green M, Jafari M, Smith TB. A case of MS presenting with SUNCT status. Headache 2010 Jan; 50(1).
Green MW, Giordano S, Jiang P, Jafari M, Smith TB. Effect of divalproex on metabolic parameters is dose related in migraine prophylaxis. Headache 2005 Sep; 45(8).
Green MW, Giordano S, Jiang P, Jafari M, Smith TB. Effect of divalproex on metabolic parameters is dose related in migraine prophylaxis. Headache 2005 Sep; 45(8).
Green MW, Giordano S, Jiang P, Jafari M, Smith TB. Long-term follow-up of chronic cluster headache treated surgically with trigeminal tractotomy. Headache 2003 May; 43(5).
Green MW, Davis DW. The emergency management of headaches. The Neurologist 2003 Mar; 9(2).
Green MW, Apfelbaum R, Caskey W, Christoffersen B, Diamond S, Graham J, Green M, Hørven I, Lund-Roland L, Medina J, Rogado S, Stein H. Long-term follow-up of chronic cluster headache treated surgically with trigeminal tractotomy. Headache 2003 May; 43(5).
Green MW, Davis DW, Caskey W, Christoffersen B, Diamond S, Graham J, Green M, Hørven I, Lund-Roland L, Medina J, Rogado S, Stein H. Hospital-affiliated headache clinics in the managed care era. Headache 1996 Sep; 36(8).
Green MW, Selman JE. Review article: the medical management of trigeminal neuralgia. Headache 1991 Oct; 31(9).
Green MW, Giordano S, Jiang P, Jafari M, Smith TB. Medical treatment of trigeminal neuralgia and cluster headache. Psychosomatics 1985 Dec; 26(12 Suppl).
Sjaastad O, Apfelbaum R, Caskey W, Christoffersen B, Diamond S, Graham J, Green M, Hørven I, Lund-Roland L, Medina J, Rogado S, Stein H. Chronic paroxysmal hemicrania (CPH). The clinical manifestations. A review. Upsala Journal of Medical Sciences. Supplement 1980; 31.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Green did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website.
Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.